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a b s t r a c t
The 2014 epidemic of Ebola virus disease (EVD) has had a devastating impact in West Africa. Sequencing
of ebolavirus (EBOV) from infected individuals has revealed extensive genetic variation, leading to
speculation that the virus may be adapting to humans, accounting for the scale of the 2014 outbreak. We
computationally analyze the variation associated with all EVD outbreaks, and ﬁnd none of the amino
acid replacements lead to identiﬁable functional changes. These changes have minimal effect on protein
structure, being neither stabilizing nor destabilizing, are not found in regions of the proteins associated
with known functions and tend to cluster in poorly constrained regions of proteins, speciﬁcally
intrinsically disordered regions. We ﬁnd no evidence that the difference between the current and
previous outbreaks is due to evolutionary changes associated with transmission to humans. Instead,
epidemiological factors are likely to be responsible for the unprecedented spread of EVD.
Crown Copyright & 2015 Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
The current ebolavirus epidemic in West Africa is characterized
by an unprecedented number of infections, and has resulted in
nearly 10,000 fatalities to date. A recent study using whole-
genome sequencing methods (Gire et al., 2014) identiﬁed high
levels of variation in the ebolavirus (EBOV), much of it unique to
the current outbreak. Speciﬁcally, 341 substitutions were found of
which 35 are non-synonymous nucleotide changes, i.e., amino-
acid residue altering. These changes, coupled with those that
occurred prior to the current outbreak, indicate that the virus is
evolving rapidly within humans. This presence of the non-
synonymous substitutions in the EBOV genomes has led to con-
cern that functional adaptation of the virus to the human host has
already occurred (Gire et al., 2014; Basler 2014), accounting for the
unusual scale and severity of the current outbreak.
According to the neutral theory of molecular evolution (Kimura
1983; Ohta 1973) most evolutionary changes at the molecular level
are inﬂuenced by genetic drift. Mutations will be subject to positive
selection if they are beneﬁcial, purifying selection if they are
deleterious, or evolve neutrally if their functional effect is neutral
or nearly-neutral. Gire et al speculate that the amino acid replace-
ments observed in the 2014–2015 EBOV population are due to
incomplete purifying selection (Gire et al., 2014). If this is the case,
we would expect replacements to be deleterious and their presence
in the population to be due to selection having insufﬁcient time to
remove them. By contrast, positive selection may arise if any
replacement increases viral ﬁtness. This may be in the form of
replacements that stabilize the protein structure, changes that have
a beneﬁcial effect on molecular function, or that permit the virus to
escape the immune system. Neutral evolution would occur if
replacements have minimal effect on ﬁtness. We expect such
replacements would be found predominantly in regions of the
proteins that are not associated with deﬁned functions, (i.e., away
from active sites and interaction sites with other molecules), have
minimal effect on protein structure, either positive or negative, and
not be in sites subject to selection from the immune system. Neutral
evolution is the null hypothesis, and should be assumed in the
absence of evidence for either positive or purifying selection.
We use the available EBOV sequence data to investigate
whether there is evidence of deleterious, functional or adaptive
changes in the viral genome. EBOV is a negative stranded RNA
virus with a genome comprising seven genes. One of these genes
(GP) gives rise to two protein products via transcriptional editing
(Sanchez et al., 1996): a membrane-bound glycoprotein and a
secreted protein. Additional functional diversity arises from VP40
existing in a number of conformational forms, which have differ-
ent functions (Bornholdt et al., 2013). Protein structural data are
available for at least part of six of the seven EBOV proteins,
including three conformational forms for VP40 (Bornholdt et al.,
2013; Gomis-Rüth et al., 2003; Hartlieb et al., 2007; Lee et al.,
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2008; Leung et al., 2009; Zhang et al., 2012; Dziubańska et al.,
2014). These data allow us to investigate the structural and
functional effects of amino acid replacements in the virus.
Results
We ﬁrst investigated whether there is evidence for positive
selection acting in any of the seven EBOV genes, using all of the
available data (1976 to present). We calculated the ratio of non-
synonymous (dN) changes to synonymous changes (dS, non-amino
acid altering). A dN/dS ratio close to 1 indicates lack of selection, o1
purifying selection, and 41 that positive selection (adaptive evolu-
tion) has taken place. For all seven genes we ﬁnd few sites with
evidence for positive selection (Fig. 1 and Supplementary Table 1).
However, except for one case, sites where dN/dS41 have very low
estimates of dS, suggesting that dN/dS ratios are unreliable in this
context. For the exception, codon 430 in GP, the single-likelihood
ancestor counting (SLAC) model estimates dN/dS to be 4.4. This
replacement is not speciﬁc to the 2014 outbreak and in a region of
the protein predicted to be intrinsically disordered. Disordered
regions are known to be permissive for residue changes because they
do not have well-deﬁned structures and so are relatively uncon-
strained (Xue and Uversky, 2014), with higher evolutionary rates than
non-disordered regions (Brown et al., 2011). There are also sites with
dN but no dS values such that the dN/dS ratio cannot be calculated.
To identify regions of enrichment for amino acid changes, we
counted the number of dN replacements within windows of a range
of sizes. Due to the relatively low number of changes, this analysis is
somewhat sensitive to window size; values for a window size of 249
nucleotides (83 codons), incremented by 45 nucleotides, are shown
in Supplementary Table 2. There is indication of enrichment towards
the C-terminal end of VP30, although this due to only two non-
synonymous changes in a region of low dS. Interestingly, we identify
enrichment for dN in regions of proteins that are predicted to be
intrinsically disordered. Altogether half of the amino acid replace-
ments (89/177 for all sequences, 21/35 for the 2014 outbreak) are in
disordered regions, despite these regions constituting only 27% of the
protein sequence (Fig. 2). In the GP protein the central disordered
section corresponds to a mucin-like protein which is highly glycosy-
lated (Sanchez et al., 1996). Within disordered sequences such as
mucin the general character of the amino-acid residue is important
for function, but, glycosylation sites aside, speciﬁc interactions are
not made, allowing a range of different amino acids to contribute to
the same functional role (Nishikawa et al., 2010). Disordered regions
have been implicated in the formation of new protein interactions
(Meszaros et al., 2009) and may permit viruses to explore novel host
perturbations via “sticky” interactions with host proteins (Xue and
Uversky, 2014). In many cases these interactions are mediated
through conserved short linear motif (SLiMs) (Davey et al., 2012)
which may be located in disordered regions (Dosztanyi et al., 2009).
Comparing predicted disorder for the various EBOV outbreak, we ﬁnd
there are no discernable differences (Fig. 4), indicating that although
disordered regions are associated with amino acid changes there are
no 2014-speciﬁc differences. When we predict binding regions
within disordered regions based on disorder analysis, we ﬁnd that
of the 89 replacements in disordered regions, 46 are in regions that
are predicted to be disordered (13 of which are 2014-speciﬁc).
However, these replacements are predicted not to change the
binding regions, with the exception of a small motif around residue
310 in GP, which is present in all outbreaks except for 1995
(Supplementary Figure 2).
As the dN/dS ratio is a relatively conservative method for detecting
functional change we computationally characterized all individual
amino acid replacements. For the amino acid replacements that fall
within a region of known protein structure (Fig. 2) we assessed the
likely functional effect of the change. To do this we used phylogenetic
methods to reconstruct the most likely sequence of the most recent
common ancestor and so the likely evolutionary trajectory. Firstly, we
assess the goodness-of-ﬁt of side chains in replacements in all proteins
(Word et al., 1999). We ﬁnd that all residue changes can be accommo-
dated in the relevant protein structure in a low energy conformation
(“rotamer”) with no substantial van der Waals overlaps (Fig. 3A).
Secondly we used an empirical potential to predict the likely structural
effect of a residue change (Guerois et al., 2002). For all replacements
that can be assessed the ΔΔG of folding associated with the amino
acid replacement has a small magnitude compared to the background
distribution (Fig. 3B) indicating that the likely effect on protein
structure is minimal. We conclude that all replacements are compa-
tible with their protein structure, and are unlikely to either increase or
decrease protein stability.
For the GP, VP30 and VP40 proteins, the available protein
structures allow identiﬁcation of many of the protein–protein
interaction interfaces i.e., those regions of amino acid sequence
responsible for virus to virus and virus to host binding. It should
be noted that these structures contain many of the important
interaction interfaces, but it is likely that both virus–virus and
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Fig. 1. Number of synonymous (dS) and non-synonymous (dN) changes per site.
Changes as calculated by the single-likelihood ancestor counting (SLAC) model
(Kosakovsky Pond and Frost, 2005). The line indicates dN¼dS.
Fig. 2. The distribution of amino acid replacements in the protein sequences.
Proteins are shown as white horizontal bars, with replacements indicated by
vertical lines. Replacements speciﬁc to the 2014 outbreak (Gire et al., 2014) are
shown in red. Regions for which the protein structure has been determined are
indicated in green, and those regions predicted to be disordered by Disopred (Ward
et al., 2004) longer than 10 residues are indicated in blue. The polymerase (L) is
broken across three lines for convenient representation.
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virus–host interactions are uncharacterized and so cannot be
included in our analysis. In total 247 interface residues were
identiﬁed (from all three proteins, including multiple VP40 con-
formation forms (Bornholdt et al., 2013)). Overwhelmingly, repla-
cements in EBOV sequences, whether from the 2014 or earlier
outbreaks, are found at sites that do not comprise interaction
interfaces. The single exception is a replacement of aspartate 47 in
GP1 to glutamate, which is not speciﬁc to the 2014 outbreak (Gire
et al., 2014). Aspartate 47 makes an intra-chain salt bridge with
lysine 588 in GP2. Structural modeling of this aspartate to
glutamate replacement in GP1 indicates that there is a low energy
conformation for glutamate that is able to make the same inter-
action with no van der Waals overlaps, suggesting this is a
functionally conservative change (Fig. 3C). Note, the crystallo-
graphic temperature factors are high for this part of the protein
structure (many are 4100), indicating that the exact positioning
of atoms is uncertain. Overall, we conclude that there is no
evidence the identiﬁed protein interaction interfaces are being
disrupted or otherwise altered by the observed amino acid
replacements.
As structures are not available for all regions we next investi-
gated the similarity of properties associated with the replacement
residues. We ﬁnd all are conservative for both hydropathy and
volume, indicated by the small magnitude of the changes relative
to the background distribution (see Supplementary Figure 1).
Larger magnitude alterations are predominantly found in regions
of the proteins that are predicted to be intrinsically disordered
which are permissive for residue changes. These changes are
therefore unlikely to affect structure or function.
A number of experimental studies have identiﬁed speciﬁc
residues that are important for various functions. These include
18 residues in GP that are important for viral entry (Brindley et al.,
2007; Manicassamy et al., 2005; Mpanju et al., 2006), ﬁve residues
in VP30 that are required for nucleocapsid incorporation (Hartlieb
et al., 2007), 23 residues in VP24 that are implicated in a range of
protein–protein interactions (Zhang et al., 2012), four residues in
VP40 that make direct contact with RNA (Gomis-Rüth et al., 2003)
and a further two residues that are essential for budding
(Bornholdt et al., 2013), and three residues in VP35 that are
required for binding RNA (Leung et al., 2010). None of these
residues are replaced in any of the EBOV lineages sequenced to
date. We also examined “second shell” residues (those in contact
with residues that play a direct role in function). Deﬁning a residue
contact using Probe we ﬁnd that there are 116 second shell
residues in total in these proteins. Only two of these are sub-
stituted. In GP, lysine 140 is implicated in viral entry to the cell
(Brindley et al., 2007), and this is in contact with arginine 219
which is substituted to lysine. In VP24 leucine 119 has a suggested
role in making protein–protein interactions (Zhang et al., 2012).
This residue contacts isoleucine 153, which is substituted for
Fig. 3. Analysis of amino acid replacements in the context of protein structure. (A) Probe score (Word et al., 1999) (arbitrary units /Å21000) for ancestral residues and
replacements. Van der Waals overlaps, if present, would result in large negative scores, whereas favorable interactions result in positive scores. (B) Change in energy (ΔΔG)
for all amino acid replacements found in regions of known protein structure, as predicted using a statistical potential. Each boxplot represents a distribution of energy
changes to all 19 other residue types at positions where a non-synonymous substitution has been observed. The ΔΔG of the observed substitution is indicated in red.
(C) Residue 47 of GP. GP1 is indicated by yellow main chain atoms and GP2 by orange. Van der Waals interactions between the side chain and surrounding atoms are shown
by all-atom contact dots (Word et al., 1999); favorable interactions are colored blue, green and yellow; no unfavorable interactions are found. D. The replacement side chain,
modeled in the tt0 rotamer (Lovell et al., 2000). Both the ancestral and replacement side chains are negatively charged, and are in close proximity to the positively charged
lysine 588 of GP2.
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valine. In both cases the replacements are conservative, and
equivalent contacts can be made with the functional residues
regardless of which of the alternative residues are present at the
substituted site.
Discussion
Collectively, the structural and functional data indicate that the
observed amino acid replacements are not found in regions of the
protein that directly contribute to known functions, and, with the
exception of GP aspartate 47, are not in any identiﬁed binding
interface. None of the observed changes are likely to either stabilize
or destabilize the protein structure. The non-synonymous changes
are physicochemically conservative, and predominantly cluster in
regions predicted to be intrinsically disordered. These changes are
likely to be neutral as disordered regions are poorly constrained.
Importantly, predictions of these disordered regions (Fig. 4) and
potential binding sites within them indicate that the changes in
these regions are not unique to the 2014 outbreak. Nonetheless
given disordered regions potential role in the formation of new
protein interactions (Meszaros et al., 2009; Xue and Uversky, 2014)
such changes need to be monitored closely.
With the exception of a small number of low-frequency frame-
shifting intrahost single nucleotide variants, we ﬁnd no evidence for
deleterious mutations that would have been consistent with incom-
plete purifying selection, as postulated by Gire et al. (2014). We also
ﬁnd no evidence of changes that are likely to be adaptive. This result
is corroborated by analysis of EBOV from a phylogenetic perspective
(Spielman et al., 2014) that similarly shows no evidence of positive
selection in the 2014 outbreak. In addition we ﬁnd no evidence of
adaptive change in any of the EBOV sequences from past outbreaks.
We conclude that none of the non-synonymous substitutions
observed to date are likely to affect protein structure or function in
any way, be it positive or negative. Thus the null hypothesis of
neutral evolution cannot be rejected based on our analysis, and is the
most reasonable explanation of the observed sequence diversity.
The reconstructed most likely genomes of the most recent
common ancestor of each outbreak demonstrate the high degree
of similarity of the progenitor virus of each outbreak. Coupled with
a lack of functional change, this similarity points to a stable viral
population in the animal reservoir, which is most likely to be fruit
bats (Pigott et al., 2014). The zoonotic nature of EBOV and
functional stability of the virus suggest that future transmission
of similarly virulent potential is highly likely. Given the dense and
highly connected nature of the human population, identiﬁcation of
the animal reservoir, surveillance and early intervention will be
the key to prevention. The relative functional stability of EBOV
suggests that intervention strategies (Pandey et al., 2014) such as
with drugs or vaccinations may be more successful than for other
RNA viruses.
It should be noted that functional change could be occurring
due to factors that we have not analyzed. Changes may alter the
function of the polymerase; this protein has only a short dis-
ordered region, and the structure is not known so it could not be
subject to many of the analyses we have used. Changes in the
intergenic regions (of which there are 14 identiﬁed in the 2014
outbreak) may be functional, and any changes may alter the
efﬁciency of replication or translation, or RNA stability. However
the 2014 outbreak is not more contagious than previous ones, has
a similar rate of fatality and the clinical presentation is similar
(Gatherer, 2015), indicating that any potential unidentiﬁed mole-
cular changes are also likely to be neutral.
The lack of functional differences and any clinical distinction
between the current and past Ebola outbreaks emphasizes the
importance of human-centric epidemiological factors over the
molecular biology and evolution of the virus (Gatherer, 2015).
The main factor that differs between the 2014 outbreak and those
that have occurred previously is the establishment of infections in
relatively densely populated areas compared with previous out-
breaks, coupled with poor health facilities (Gatherer, 2014).
Human population growth and progressive urbanization have
created efﬁcient pathways for viral transmission (Pigott et al.,
2014) despite a comparably low basic reproductive number, R0
(Gatherer, 2014).
Evolution of a change in mode of transmission of EBOV is
extremely unlikely, due to the highly speciﬁc and intricate nature
by which viruses interact with their hosts. Of more concern is the
possibility that R0, the number of transmissions per infection,
increases. Due to the unusually deadly nature of EBOV, a milder
virus with even a substantial drop in virulence would still
frequently result in deadly infections on an epidemic or pandemic
scale. Despite no observable functional change between 1976 and
mid-2014, future functional change is possible, emphasizing the
need for continued monitoring of viral evolution.
Methods
Ebolavirus sequences were obtained from GenBank, see Gire
et al. (2014) for accession numbers. In total 101 sequences were
used. Protein structural data was as follows: NP, PDB code 4QAZ
Fig. 4. Prediction of disorder for GP, L and NP for sequences from each outbreak. Predictions were made with IUPred (Dosztanyi et al., 2005). The recommended cut off (0.4)
for considering protein regions disordered is indicated.
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(Dziubańska et al., 2014); VP35, PDB code 3FKE (Leung et al.,
2009); GP, PDB code 3CSY (Lee et al., 2008); VP30, PDB code 2I8B
(Hartlieb et al., 2007); VP24 PDB code 3VNE (Zhang et al., 2012).
For VP40, multiple conformations are available, and all were
assessed: PDB codes 4LDD, 4LDM, 4LDB (Bornholdt et al., 2013)
and 1H2C (Gomis-Rüth et al., 2003).
The sequences were aligned and phylogenetic trees were
estimated using the WAG substitution model (Whelan and
Goldman, 2001), implemented in RAXML (Stamatakis, 2014).
Ancestral sequences of EBOV proteins were reconstructed using
maximum likelihood, implemented by FastML (Ashkenazy et al.,
2012). Using ancestral reconstruction, the evolutionary pathway
for every EBOV sequence in our data set was traced to the last
common ancestor, and the sequence of every internal node was
compared with that of its ancestor.
The energy change for all amino acid replacements that fall
within regions of known structure was predicted using an empiri-
cal force ﬁeld as implemented in FoldX software (version 3 Beta 6).
Mutant structures were generated using the “build model” func-
tion in FoldX by mutating the native residue in the wild type with
the 19 other possible amino acid residues for each position where
a non-synonymous mutation was observed. Where the sequence
of the native protein differed from that of the crystal structure, the
structure was predicted using Modeller (Sali and Blundell, 1993).
Goodness-of-ﬁt of replacement residues in the context of the
protein structure was calculated using Probe (Word et al., 1999)
after addition of hydrogen atoms with Reduce (Word et al., 1999).
Probe was also used to identify residues in interaction interfaces.
In each case all low energy conformations (“rotamers”) (Lovell et
al., 2000) were assessed, and the rotamer with the best Probe
score was used. For replacement valine 325 to isoleucine in VP35,
we use the conformation of χ1¼–451 χ2¼–501, which is not the
bottom of the energy well, but is nevertheless a favorable side
chain conformation. For both FoldX and Probe analyses residues
were substituted individually. This is appropriate, as there are no
examples where substituted residues are in contact.
The SLAC method as implemented by the Datamonkey webser-
ver (Kosakovsky Pond and Frost, 2005) (http://www.datamonkey.
org) was used to estimate dN (nonsynonymous) and dS (synon-
ymous) rates for each protein. This method estimates the dN and dS
rates for each codon site and compare the observed rates with null
expectations based on the used nucleotide substitution model.
Residue volumes were taken from Zamyatnin (1972) and hydro-
pathy scales from Kyte and Doolittle (1982). Disordered regions of
proteins were predicted by DISOPRED (Ward et al., 2004) and
IUPred (Dosztanyi et al., 2005). Predictions of binding regions
(potential SLiMs) based on analysis of disorder using ANCHOR
(Dosztanyi et al., 2009).
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